10x Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	359.28	227.35	596.07	688.64	476.49	70.09	47.86
Short-Term Investments	29.41	210.24	0	0	0	0	0
Cash & Cash Equivalents	388.7	437.59	596.07	688.64	476.49	70.09	47.86
Cash Growth	-11.17%	-26.59%	-13.44%	44.52%	579.85%	46.45%	-
Receivables	114.83	104.21	85.25	51.21	33.37	28.09	13.34
Inventory	73.71	81.63	59.97	29.96	15.27	8.57	4.84
Other Current Assets	18.79	11.6	6.3	4.56	-44.29	-0.51	2.07
Total Current Assets	596.02	635.04	747.59	774.37	480.84	106.24	68.11
Property, Plant & Equipment	344.93	359.21	230.41	119.82	48.82	11.13	6.93
Goodwill and Intangibles	21.13	27.37	29.91	22.35	0	0	0
Other Long-Term Assets	3.06	7.37	10.92	12.8	76.26	6.95	0.58
Total Long-Term Assets	369.12	393.95	271.24	154.98	125.08	18.07	7.5
Total Assets	965.14	1,029	1,019	929.34	605.92	124.31	75.61
Accounts Payable	15.74	21.6	17.35	4.71	13.03	8.79	5.44
Deferred Revenue	21.96	11.03	5.34	4.47	3.3	3.5	1.83
Current Debt	11.52	9.04	5.13	5.94	9.88	4.19	4.22
Other Current Liabilities	77.94	89.29	82.54	103.01	36.84	15.89	10.65
Total Current Liabilities	127.16	130.96	110.36	118.13	63.05	32.36	22.14
Long-Term Debt	83.85	86.14	76.85	57.04	19.84	25.49	6.34
Other Long-Term Liabilities	13.09	6.14	14.05	15.1	102.95	43.2	1.23
Total Long-Term Liabilities	96.94	92.28	90.9	72.14	122.79	68.69	7.56
Total Liabilities	224.1	223.24	201.26	190.27	185.84	101.05	29.7
Total Debt	95.37	95.18	81.98	62.98	29.72	29.68	10.56
Debt Growth	0.20%	16.10%	30.17%	111.91%	0.14%	181.05%	-
Retained Earnings	-1,284.42	-1,029.32	-863.32	-805.1	-262.37	-231.12	-118.63
Comprehensive Income	-0.43	-4.34	0.02	-0.05	-0.05	-0.04	-0.02
Shareholders' Equity	741.04	805.74	817.57	739.07	420.08	-219.99	-112.51
Net Cash / Debt	293.33	342.42	514.1	625.67	446.77	40.41	37.3
Net Cash / Debt Growth	-14.34%	-33.39%	-17.83%	40.04%	1005.55%	8.35%	-
Net Cash Per Share	2.50	3.01	4.66	6.19	11.43	3.02	3.22
Working Capital	468.86	504.08	637.23	656.24	417.79	73.87	45.97
Book Value Per Share	6.33	7.08	7.41	7.31	10.75	-16.43	-9.71

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).